Eustace Santa Barbara highlights opportunities in ‘lab-grown’ meat

Marlborough UK Micro-Cap Growth Co-Manager Eustace Santa Barbara has spoken to Investment Week about why the fund is backing Agronomics, an AIM-listed company that invests in businesses in the field of cellular agriculture.

This includes companies producing ‘lab-grown’ meat, where scientists grow meat using cells taken from a sample of animal tissue.

Eustace says the process has huge potential advantages, using half the energy of conventional food production methods. It needs a fraction of the land and water used in traditional farming and greenhouse gas emissions are estimated to be around 95% lower.

His comments appear in a ‘deep dive’ article about the prospects for UK smaller companies. While the piece says investors remain wary, it quotes one commentator who says UK small caps now represent a ‘very attractive valuation opportunity’.

27/01/23

Read the article here

For professional use only.

Capital is at risk. The value and income from investments can go down as well as up and are not guaranteed. An investor may get back significantly less than they invest. Past performance is not a reliable indicator of current or future performance and should not be the sole factor considered when selecting funds.